𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy

✍ Scribed by E. A. Marsh; C. L. Hirst; J. G. Llewelyn; M. D. Cossburn; M. M. Reilly; A. Krishnan; M. Doran; A. M. Ryan; A. J. Coles; J. L. Jones; N. P. Robertson

Publisher
Springer
Year
2010
Tongue
English
Weight
227 KB
Volume
257
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of chronic inflammatory demyel
Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin
✍ Dr. David R. Cornblath; Vinay Chaudhry; John W. Griffin πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 305 KB πŸ‘ 2 views

## Abstract Chronic inflammatory demyelinating polyneuropathy is an immune‐mediated demyelinating peripheral neuropathy usually treated with immunosuppressants. We reviewed our experience treating 15 patients (9 men, 6 women) with intravenous immunoglobulin. Six patients were on other therapies at

Activity-dependent excitability changes
Activity-dependent excitability changes in chronic inflammatory demyelinating polyneuropathy: A microneurographic study
✍ Satoshi Kuwabara; Yoshio Nakajima; Takamichi Hattori; Shinobu Toma; Keiko Mizobu πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 156 KB πŸ‘ 2 views

The purpose of this study was to investigate activitydependent excitability changes in polyneuropathy and their correlation with symptomatology. First, we recorded sensory nerve action potentials (SNAPs) with an intraneural microelectrode during impulse trains in 11 patients with chronic inflammator